LifeSteps Financial’s MiNK Therapeutics INKT Stock Holding History

LifeSteps Financial’s Portfolio INKT Stock Details INKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23	Buy	+2	New	+$23	﹤0.01%	784
2024 Q2	–	Sell	-3	Closed	-$25	–	228
2024 Q1	$25	Buy	+3	New	+$28	﹤0.01%	439

Other funds holding INKT

Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return

KFI

Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return

LifeSteps Financial's INKT Position: Q2 2026 in Review

LifeSteps Financial opened a new position in MiNK Therapeutics (INKT) in Q2 2026: 2 shares worth $23. The stake represents ﹤0.01% of the portfolio and ranks #784 among its holdings. This is a return to the name: LifeSteps Financial previously reported a position in INKT as recently as Q1 2024.

LifeSteps Financial first reported a position in INKT in Q1 2024 and has held it in 2 quarters since. The position peaked at $25 in Q1 2024. 3 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

LifeSteps Financial held 2 shares of MiNK Therapeutics worth $23 as of Q2 2026.
MiNK Therapeutics was a new LifeSteps Financial position in Q2 2026.
MiNK Therapeutics made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #784 holding.
LifeSteps Financial first reported a position in MiNK Therapeutics in Q1 2024 and has held it in 2 quarters since.
LifeSteps Financial's MiNK Therapeutics position peaked at $25 in Q1 2024.
3 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.